New Type of PTH Testing May Help Predict HD Patient Death Risk

Share this content:

A new study suggests that non-oxidized, biologically active parathyroid hormone (PTH) testing may help determine mortality risk in hemodialysis patients.

John Schieszer reports in today's Medical Minute that current testing methods for PTH levels may overlook a key element.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters